Literature DB >> 12042937

MRI features of primary, secondary and metastatic medulloblastoma.

U Bühring1, M Strayle-Batra, D Freudenstein, H-G Scheel-Walter, W Küker.   

Abstract

Medulloblastoma is the most frequent paediatric malignant brain tumour. The purpose of this study was to define imaging characteristics and contrast uptake patterns of primary and recurrent medulloblastoma using MRI. The MRI examinations of 17 histologically proven cases of medulloblastoma diagnosed in our institution (13 males and 4 females; mean age 13 years, 7 months) were reviewed in retrospect. Only patients with pre-treatment and follow-up examinations including T2-weighted images (fluid-attenuated inversion recovery or turbo spin echo) and T1-weighted images after contrast injection (0.1 mmol/kg Gd-DTPA) were included in this study. Whereas 6 of 7 tumours ( n=17) were hyperintense on T2-weighted images, contrast enhancement was detected in 13 patients. Fifteen tumours occurred in the cerebellar vermis, two were located in the cerebellar hemispheres. Mean size at the time of presentation was 30.1 mm. All patients presented with some extent of an occlusive hydrocephalus. Local recurrent tumour or metastases were seen in 6 patients (3 months to 7 years, mean age 2.5 years). Whereas the T2 signal intensity of recurrent tumour or subarachnoidal metastases resembled the primary neoplasms, the contrast uptake tended to be less pronounced ( n=3) or was completely absent ( n=2); thus, suggestive signs of primary medulloblastoma are location in the vermis, hyperintensity on T2-weighted images and hydrocephalus. The amount of contrast enhancement is variable and nonspecific. Secondary medulloblastoma manifestation is characterized by T2 hyperintensity but not by contrast uptake.

Entities:  

Mesh:

Year:  2001        PMID: 12042937     DOI: 10.1007/s00330-001-1189-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  10 in total

1.  Magnetic resonance imaging spectrum of medulloblastoma.

Authors:  Julia Fruehwald-Pallamar; Stefan B Puchner; Andrea Rossi; Maria L Garre; Armando Cama; Claus Koelblinger; Anne G Osborn; Majda M Thurnher
Journal:  Neuroradiology       Date:  2011-01-29       Impact factor: 2.804

2.  Freiburg Neuropathology Case Conference : Posterior Fossa Mass in an Infant.

Authors:  C A Taschner; D Erny; M J Shah; H Urbach; U Feige; M Prinz
Journal:  Clin Neuroradiol       Date:  2019-03       Impact factor: 3.649

Review 3.  Initial management of childhood brain tumors: neurosurgical considerations.

Authors:  Farideh Nejat; Mostafa El Khashab; James T Rutka
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

4.  Your diagnosis? A 12-year-old girl with latent tuberculosis presenting with nausea, vomiting and increasing frontal headache.

Authors:  Marina De Gaudio; Elena Chiappini; Piera Catania; Federico Mussa; Luisa Galli; Maurizio de Martino
Journal:  Eur J Pediatr       Date:  2008-09-13       Impact factor: 3.183

5.  The Neuroradiological Spectra of Adult and Pediatric Medulloblastoma Differ : Results from a Literature-based Meta-analysis.

Authors:  Dagmar Beier; Selin Kocakaya; Peter Hau; Christoph Patrick Beier
Journal:  Clin Neuroradiol       Date:  2016-06-22       Impact factor: 3.649

Review 6.  Clinical application of 18F-DOPA PET/TC in pediatric patients.

Authors:  Gabriele Masselli; Emanuele Casciani; Cristina De Angelis; Saadi Sollaku; Gianfranco Gualdi
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-04-15

7.  MRI surrogates for molecular subgroups of medulloblastoma.

Authors:  S Perreault; V Ramaswamy; A S Achrol; K Chao; T T Liu; D Shih; M Remke; S Schubert; E Bouffet; P G Fisher; S Partap; H Vogel; M D Taylor; Y J Cho; K W Yeom
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-15       Impact factor: 3.825

8.  Magnetic resonance spectroscopy findings in non-enhancing desmoplastic medulloblastoma.

Authors:  Puneet Mittal
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

9.  Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours.

Authors:  Maria Łastowska; Elżbieta Jurkiewicz; Joanna Trubicka; Paweł Daszkiewicz; Monika Drogosiewicz; Katarzyna Malczyk; Wiesława Grajkowska; Ewa Matyja; Bożena Cukrowska; Maciej Pronicki; Marta Perek-Polnik; Danuta Perek; Bożenna Dembowska-Bagińska
Journal:  J Neurooncol       Date:  2015-04-11       Impact factor: 4.130

10.  Added value of diffusion weighted imaging in pediatric central nervous system embryonal tumors surveillance.

Authors:  Giovanni Morana; Cesar Augusto Alves; Domenico Tortora; Mariasavina Severino; Paolo Nozza; Armando Cama; Marcello Ravegnani; Gabriella D'Apolito; Alessandro Raso; Claudia Milanaccio; Claudia da Costa Leite; Maria Luisa Garrè; Andrea Rossi
Journal:  Oncotarget       Date:  2017-07-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.